secwatch.observer — SEC 8-K summary
======================================

Issuer:     Surgery Partners, Inc. (SGRY)
CIK:        0001638833
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001638833-24-000006
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02
LLM model:  deepseek-v4-flash:cloud@v2

Surgery Partners reaffirms 2023 guidance, projects 2024 Adj. EBITDA >$495M
--------------------------------------------------------------------------

- Reaffirmed 2023 Adjusted EBITDA guidance of $436M-$440M; revenue ~$2.75B.
- Projected 2024 Adjusted EBITDA greater than $495 million, implying ~13% YoY growth.
- Guidance based on results through November 2023, subject to year-end adjustments.
- Company updated investors at J.P. Morgan Healthcare Conference on January 8, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638833/000163883324000006/0001638833-24-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638833/000163883324000006/sgry-20240108.htm
  HTML page:      https://secwatch.observer/filing/0001638833-24-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer